News Drug Dosages Questioned in Diabetic Macular Edema Trial by Medscape • 2015/07/18 • 0 Comments Experts wonder whether increased doses might eliminate the advantages seen with aflibercept over bevacizumab and ranibizumab in a diabetic macular edema trial. Medscape Medical News Full Story →